Ascletis Pharma Inc. (OTCMKTS:ASCLF) Short Interest Update

Ascletis Pharma Inc. (OTCMKTS:ASCLF) was the target of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 456,545 shares, a growth of 146.1% from the December 31st total of 185,545 shares. Based on an average daily volume of 3,676 shares, the short-interest ratio is currently 124.2 days. Based on an average daily volume of 3,676 shares, the short-interest ratio is currently 124.2 days.

Ascletis Pharma Price Performance

Shares of ASCLF opened at $1.76 on Friday. The stock’s 50-day moving average price is $1.73 and its two-hundred day moving average price is $1.54. Ascletis Pharma has a 12 month low of $0.62 and a 12 month high of $2.29.

About Ascletis Pharma

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).